Document is current
Any future updates will be listed below
-
Authors
Marx, Nikolaus
Floege, Jürgen
- License Information
-
More Information
Article History
Accepted: 3 February 2021
First Online: 10 June 2021
Conflict of interest
: N. Marx has received support for clinical trial leadership from Boehringer Ingelheim, Novo Nordisk, served as a consultant to Boehringer Ingelheim, Merck, Novo Nordisk, AstraZeneca, BMS, received grant support from Boehringer Ingelheim, Merck, Novo Nordisk, and served as a speaker for Boehringer Ingelheim, Merck, NovoNordisk, Lilly, BMS, and Astra Zeneca. N. Marx declines all personal compensation from pharma ordevice companies. J. Floege served as a consultant to Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, and Novo Nordisk.
Free to read: This content has been made available to all.
